Tell us about allergies, medications, and medical conditions so Dr
While none have yet received official approval, ongoing clinical trials may pave the way for targeted treatments in the future
Selective NNMT inhibitors (including 5-Amino-1MQ) lower 1-MNA, increase NAD and SAM, suppress adipocyte lipogenesis, and reverse HFD-induced obesity in mice [1]
They act through an initial electrostatic interaction with the negatively charged compounds of the bacterial cytoplasmic membrane followed by insertion and permeabilization of the membrane
MIC stands for methionine, inositol, and choline lipotropic agents that help break down fat
The clinical translation of those findings to an oral supplement context has not been established through published human pharmacokinetic data